Table of Contents Author Guidelines Submit a Manuscript
Journal of Nutrition and Metabolism
Volume 2014, Article ID 498497, 5 pages
http://dx.doi.org/10.1155/2014/498497
Clinical Study

Study of Body Composition and Metabolic Parameters in HIV-1 Male Patients

Department of General Medicine, Regional Institute of Medical Sciences, Imphal 795004, India

Received 23 January 2014; Revised 11 May 2014; Accepted 12 May 2014; Published 10 June 2014

Academic Editor: Phillip B. Hylemon

Copyright © 2014 Gurudath Gundurao Sreekantamurthy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Carr, K. Samaras, S. Burton et al., “A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors,” AIDS, vol. 12, no. 7, pp. F51–F58, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Grunfeld, “Disturbances in lipid metabolism due to HIV infection and its therapy,” in Proceedings of the Conference on Retroviruses and Opportunistic Infections, vol. 6, Chicago, Ill, USA, 1999.
  3. R. Thiébaut, F. Dabis, D. Malvy, H. Jacqmin-Gadda, P. Mercié, and V. Daucourt Valentin, “Serum triglycerides, HIV infection, and highly active antiretroviral therapy, Aquitaine Cohort, France, 1996 to 1998,” Journal of Acquired Immune Deficiency Syndromes, vol. 23, no. 3, pp. 261–265, 2000. View at Google Scholar · View at Scopus
  4. C. J. Smith, I. Levy, C. A. Sabin, E. Kaya, M. A. Johnson, and M. C. I. Lipman, “Cardiovascular disease risk factors and antiretroviral therapy in an HIV-positive UK population,” HIV Medicine, vol. 5, no. 2, pp. 88–92, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. Waist Circumference and Waist-Hip Ratio. A Report of WHO Expert Consultation, Geneva, Switzerland, 2008.
  6. M. Kanazawa, N. Yoshiike, T. Osaka, Y. Numba, P. Zimmet, and S. Inoue, “Criteria and classi—cation of obesity in Japan and Asia-Oceania,” Asia Pacific Journal of Clinical Nutrition, vol. 11, pp. 732–737, 2002. View at Google Scholar
  7. Z. Wang et al., “Japanese-American differences in visceral adiposity and a simplified estimation method for visceral adipose tissue,” in North American Association for the Study of Obesity. Annual Meeting, 2004, Abstract 518-P.
  8. D. Gallagher, S. B. Heymsfield, M. Heo, S. A. Jebb, P. R. Murgatroyd, and Y. Sakamoto, “Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index,” American Journal of Clinical Nutrition, vol. 72, no. 3, pp. 694–701, 2000. View at Google Scholar · View at Scopus
  9. W. L. Dinges, D. Chen, P. G. Snell, P. T. Weatherall, D. M. Peterson, and A. Garg, “Regional body fat distribution in HIV-infected patients with lipodystrophy,” Journal of Investigative Medicine, vol. 53, no. 1, pp. 15–25, 2005. View at Google Scholar · View at Scopus
  10. A. Carr, K. Samaras, D. J. Chisholm, and D. A. Cooper, “Abnormal fat distribution and use of protease inhibitors,” The Lancet, vol. 351, no. 9117, p. 1736, 1998. View at Google Scholar · View at Scopus
  11. K. Mulligan, C. Grunfeld, V. W. Tai et al., “Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection,” Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 23, no. 1, pp. 35–43, 2000. View at Google Scholar · View at Scopus
  12. K. Samaras, H. Wand, L. Matthew, S. Emery, D. Cooper, and A. Carr, “Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia,” Diabetes Care, vol. 30, no. 1, pp. 113–119, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Saint-Marc, M. Partisani, I. Poizot-Martin et al., “A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy,” AIDS, vol. 13, no. 13, pp. 1659–1667, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Domingo, M. A. Sambeat, A. Pérez, J. Ordoñez, J. Rodriguez, and O. Vázquez, “Fat distribution and metabolic abnormalities in HIV-infected patients on first combination antiretroviral therapy including stavudine or zidovudine: role of physical activity as a protective factor,” Antiviral Therapy, vol. 8, no. 3, pp. 223–231, 2003. View at Google Scholar · View at Scopus
  15. S. A. Mallal, M. John, C. B. Moore, I. R. James, and E. J. McKinnon, “Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection,” AIDS, vol. 14, no. 10, pp. 1309–1316, 2000. View at Publisher · View at Google Scholar · View at Scopus